12 results
20-F
2022 FY
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Aug 22
Annual report (foreign)
4:20pm
IPO.
Failure to comply with anticorruption and anti-money laundering laws, including the FCPA and similar laws associated with activities outside
424B4
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
21 Jul 22
Prospectus supplement with pricing info
10:01am
to comply with anticorruption and anti-money laundering laws, including the FCPA and similar laws associated with activities outside of the United States
FWP
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
30 Jun 22
Free writing prospectus
9:04pm
to restrictions under Rule 144 under the Securities Act, which could impact the trading price of our Ordinary Shares. Failure to comply with anticorruption
FWP
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
30 Jun 22
Free writing prospectus
1:29pm
to restrictions under Rule 144 under the Securities Act, which could impact the trading price of our Ordinary Shares. Failure to comply with anticorruption
F-1/A
4ry1e vo03
24 Jun 22
Registration statement (foreign) (amended)
9:47pm
F-1/A
kxt zkirkxadlp
24 Jun 22
Registration statement (foreign) (amended)
8:21am
F-1/A
lv2lxd
21 Jun 22
Registration statement (foreign) (amended)
6:26am
F-1/A
gb31fkcvfps b3s
6 Jun 22
Registration statement (foreign) (amended)
6:13pm
F-1/A
6sgg3va00o042oxa h0
11 May 22
Registration statement (foreign) (amended)
3:11pm
F-1/A
k6fn0upg
22 Apr 22
Registration statement (foreign) (amended)
6:09pm
F-1
w3u2nnysz8bbusidlu
18 Mar 22
Registration statement (foreign)
3:50pm
- Prev
- 1
- Next